IMC Presentation Statement
SkinBioTherapeutics plc will present to shareholders today, June 29, 2026, at 09:00 BST on the Investor Meet Company platform, covering recent post-period events, findings from the FRP Advisory report, and HY26 results, alongside post-period trading and outlook. The company will confirm that its FY26 results will be prepared on a going concern basis.
Select text to share a quote on X · sign in to keep highlights & notes in your SBTX notes
29 June 2026 - SkinBioTherapeutics plc, (AIM: SBTX), the life science business focused on skin health, will be presenting to shareholders at 09.00 BST today, Monday 29 June 2026 on the Investor Meet Company platform (see details below). The presentation will be led by Alyson Levett, Acting Chair and Rachel Parsonage, Interim CEO.
The presentation will be brief and cover recent post period events, the investigation and the disclosable information from the FRP Advisory report, before running through the recent HY26 results, post period trading and outlook. The Company will also be stating that the FY26 results will be prepared on a going concern basis.
Presentation details
The presentation is open to all existing and potential shareholders. Questions can be submitted at any time during the live presentation. Investors can sign up to Investor Meet Company for free and add to meet SkinBioTherapeutics via the link HERE. Investors who already follow SkinBioTherapeutics on the Investor Meet Company platform will automatically be invited.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.